Researchers Awarded $900,000 Grant to Develop Drug to Fight Cancer
Wei Gao, PhD, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer Prevention and Research Institute of Texas to develop a stronger and more targeted anti-tumor therapy for pancreatic and lung cancer.
HHS Invests $100 Million for Great American Recovery
The U.S. Health and Human Services (HHS) has developed a comprehensive plan to strengthen prevention, expand treatment and carry out the the Great American Recovery.
$1.6 Million Grant Awarded for Hepatitis B Vaccine Research
The Centers for Disease Control and Prevention (CDC) has awarded an unsolicited $1.6 million grant for vaccine research to Danish researchers whose studies have been challenged by mainstream scientists but championed by anti-vaccine activists
$2.7 Million Grant Awarded for NSCLC Research
Trethera Corp. has been awarded a new $2.7 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
HHS Doubles AI-Backed Cancer Research Funding
The U.S. Department of Health and Human Services has doubled funding for its Childhood Cancer Data Initiative at the National Institutes of Health
NIH Launches $50 Million Autism Data Science Initiative
The National Institutes of Health launched the $50 Million Autism Data Science Initiative, supporting 13 pioneering projects
$3.4 Million Grant Awarded to Study Treatments for CCHFV
The National Institutes of Health granted Scott Pegan, PhD, nearly $3.4 million to lead an study to develop protective antibodies against Crimean Congo hemorrhagic fever virus
NIH Grant Awarded to Study Treatment for Crohn’s Disease
Trethera Corp., a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, has been awarded a $1.8 million National Institutes of Health (NIH) grant for preclinical studies of TRE515 as a Crohn’s disease treatment. TRE515 is a once-daily oral therapy that inhibits deoxycytidine kinase (dCK), an enzyme critical to the deoxyribonucleoside salvage […]
NIH Changes Terms and Conditions Governing Federal Grants
The National Institutes of Health announced a significant change to the terms and conditions governing federal funding applicable to all NIH grants, cooperative agreements and other awards, including future awards.
FDA Requires Major Changes to Opioid Pain Medication Labeling
The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use.